Arla Foods Ingredients Group P/S:企業の戦略・SWOT・財務情報

◆英語タイトル:Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4104
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Arla Foods Ingredients Group P/S – Strategy, SWOT and Corporate Finance Report
Summary

Arla Foods Ingredients Group P/S – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Arla Foods Ingredients Group P/S (AFI), a subsidiary of Arla Foods amba, develops and produces natural milk whey-based functional and nutritional ingredients. The company’s product portfolio includes permeate, lactose and nutritional ingredients such as alpha-lactalbumin, caseinoglycomacropeptide, casein phosphopeptide and whey hydrolysates. AFI markets its products under Lacprodan, Capolac, Nutrilac, Variolac and Peptigen brands. Its products find applications in cheese, bakery products, ice cream, clinical nutrition products, functional foods, infant nutrition and sports nutrition products. It operates production plants in Denmark, Argentina, Germany and the UK. AFI is headquartered in Viby J, Aarhus, Denmark.

Scope

- Detailed information on Arla Foods Ingredients Group P/S required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Arla Foods Ingredients Group P/S in the form of a SWOT analysis
- An in-depth view of the business model of Arla Foods Ingredients Group P/S including a breakdown and examination of key business segments
- Intelligence on Arla Foods Ingredients Group P/S’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Arla Foods Ingredients Group P/S, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Arla Foods Ingredients Group P/S and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Arla Foods Ingredients Group P/S as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Arla Foods Ingredients Group P/S’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Arla Foods Ingredients Group P/S: Company Overview 6
Arla Foods Ingredients Group P/S: Overview and Key Facts 6
Arla Foods Ingredients Group P/S: Overview 6
Arla Foods Ingredients Group P/S: Key Facts 6
Arla Foods Ingredients Group P/S: Key Employees 7
Arla Foods Ingredients Group P/S: Major Products and Services 8
Arla Foods Ingredients Group P/S: Company History 9
Arla Foods Ingredients Group P/S: Locations and Subsidiaries 11
Arla Foods Ingredients Group P/S: Key Competitors 12
Arla Foods Ingredients Group P/S: Company Analysis 13
Arla Foods Ingredients Group P/S: Business Description 13
Arla Foods Ingredients Group P/S: SWOT Analysis 15
Arla Foods Ingredients Group P/S: SWOT Overview 15
Arla Foods Ingredients Group P/S: Strengths 15
Arla Foods Ingredients Group P/S: Weaknesses 16
Arla Foods Ingredients Group P/S: Opportunities 16
Arla Foods Ingredients Group P/S: Threats 17
Arla Foods Ingredients Group P/S: Recent Developments 19
Arla Foods Ingredients Group P/S: News and Events Summary 19
Arla Foods Ingredients Group P/S: Business Expansion 19
Arla Foods Ingredients Group P/S: Strategy and Operations 20
Appendix 21
Contact Us 21
Methodology 21
About MarketLine 22

List of Tables
Table 1: Arla Foods Ingredients Group P/S: Key Facts
Table 2: Arla Foods Ingredients Group P/S: Key Employees
Table 3: Arla Foods Ingredients Group P/S: Locations and Subsidiaries
Table 4: Arla Foods Ingredients Group P/S: Key Competitors
Table 5: Arla Foods Ingredients Group P/S: News and Events Summary
Table 6: Arla Foods Ingredients Group P/S: Business Expansion
Table 7: Arla Foods Ingredients Group P/S: Strategy and Operations



★海外企業調査レポート[Arla Foods Ingredients Group P/S:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oxford Immunotec Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.T …
  • JDC Group AG:企業のM&A・事業提携・投資動向
    JDC Group AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JDC Group AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Distell Group Limited:企業の戦略・SWOT・財務情報
    Distell Group Limited - Strategy, SWOT and Corporate Finance Report Summary Distell Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sarepta Therapeutics Inc (SRPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Sarepta Therapeutics Inc (Sarepta) is discovers and develops unique RNA-targeted therapeutics, gene therapy and other genetic medicine approaches to treat rare neuromuscular diseases. The company develops drugs based on its proprietary, highly-differentiated and innovative platform technolog …
  • Arch Capital Group Ltd.:戦略・SWOT・企業財務分析
    Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ascom Holding AG:企業のM&A・事業提携・投資動向
    Ascom Holding AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ascom Holding AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Neiman Marcus Group LTD LLC:戦略・SWOT・企業財務分析
    Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report Summary Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • KPC Pharmaceuticals Inc (600422)-製薬・医療分野:企業M&A・提携分析
    Summary KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and botanical drugs. It also offers drugs such as xue …
  • Airbus SAS:戦略・SWOT・企業財務分析
    Airbus SAS - Strategy, SWOT and Corporate Finance Report Summary Airbus SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cubic Corp (CUB):企業の財務・戦略的SWOT分析
    Cubic Corp (CUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Caspian Energy Inc (CKZ.H):石油・ガス:M&Aディール及び事業提携情報
    Summary Caspian Energy Inc (CEI) is an independent upstream oil and gas company. It carries out the exploration, development, and production of oil and gas. and the company, along with its subsidiaries hold interests in Aral Petroleum Capital LLP, which holds an exclusive license to explore and deve …
  • Mother Dairy Fruit & Vegetable Pvt. Ltd.:企業の戦略的SWOT分析
    Mother Dairy Fruit & Vegetable Pvt. Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • RBC Wealth Management:企業の戦略・SWOT・財務分析
    RBC Wealth Management - Strategy, SWOT and Corporate Finance Report Summary RBC Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • C-TRI Co Ltd (047920):製薬・医療:M&Aディール及び事業提携情報
    Summary C-TRI Co Ltd (C-TRI), a subsidiary of DAE HWA Pharmaceutical Co Ltd, is a pharmaceutical company that offers development of new peptide drugs. The company’s products include ethicals, over-the-counter drugs, Quasi-drugs, cosmetics, amendments, pharmaceuticals, taltirelin, desmopressin, presc …
  • Medicines for Malaria Venture:企業のM&A・事業提携・投資動向
    Medicines for Malaria Venture - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Medicines for Malaria Venture Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • PT Perusahaan Gas Negara (Persero) Tbk (PGAS):企業の財務・戦略的SWOT分析
    PT Perusahaan Gas Negara (Persero) Tbk (PGAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Steel Reef Infrastructure Corp-石油・ガス分野:企業M&A・提携分析
    Summary Steel Reef Infrastructure Corp (Steel Reef) is a mid-stream company that focuses on long-term returns through investments in small to midsized infrastructure with focus on the Western Canadian Sedimentary Basin. The company carries out the construction, operation and optimization of oil and …
  • Inretail Peru Corp. (INRETC1):企業の財務・戦略的SWOT分析
    Inretail Peru Corp. (INRETC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Lukoil Oil Co (LKOH):電力:M&Aディール及び事業提携情報
    Summary Lukoil Oil Company (Lukoil) is a vertically integrated oil and gas company, which carries out exploration and production of crude oil and natural gas. Lukoil has interest in properties across Russia, Kazakhstan, Azerbaijan, Uzbekistan, the Middle East, South America, Northern and Western Afr …
  • Celon Pharma SA (CLN)-製薬・医療分野:企業M&A・提携分析
    Summary Celon Pharma SA (Celon Pharma) is an integrated pharmaceutical company which carries out research and develops novel therapies. Its product portfolio includes Aromek, Salmex, Valzek, Lazivir, Bosentan Celon, Donepex and Ketrel. The company primarily focuses on the development of pharmaceutic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆